Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01122576
Other study ID # 651
Secondary ID
Status Completed
Phase Phase 4
First received May 11, 2010
Last updated February 12, 2014
Start date June 2010
Est. completion date September 2012

Study information

Verified date February 2014
Source Bausch & Lomb Incorporated
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The objective of this study is to evaluate the efficacy and subject satisfaction with three different FDA approved lenses for adults over 40 years of age who desire a reduction in spectacle dependence.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date September 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender Both
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Subjects must have a clinically documented diagnosis of age-related bilateral cataracts that are considered amenable to treatment with standard phacoemulsification cataract extraction.

- Subjects must require a spherical lens power from 10.00 D to 33.00 D

- Subjects must have the potential for corrected distance visual acuity (CDVA) of 20/32 or better in both eyes, as documented by a Potential Acuity Meter

Exclusion Criteria:

- Subjects with conditions with increased risk of zonular rupture, such as pseudoexfoliation syndrome. Zonular rupture during cataract surgery may affect postoperative centration, tilt, and stability of the lens.

- Subjects who have any active inflammation or edema (swelling) of the cornea, including but not limited to the following: keratitis, keratoconjunctivitis, and keratouveitis.

- Subjects with visually significant diabetic retinopathy (proliferative or non-proliferative) which reduces potential acuity to 20/32 or worse.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Crystalens AO
Crystalens AO surgically implanted bilaterally. Study observation up to 180 days.
ReSTOR
ReSTOR surgically implanted bilaterally. Study observation up to 180 days.
Tecnis Multifocal IOL
Tecnis surgically implanted bilaterally. Study observation up to 180 days.

Locations

Country Name City State
United States Bausch & Lomb, Inc Aliso Viejo California

Sponsors (1)

Lead Sponsor Collaborator
Bausch & Lomb Incorporated

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mesopic Monocular Contrast Sensitivity Without Glare 1.5 and 3 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Postoperative visit 3 (2-3 months) No
Primary Mesopic Monocular Contrast Sensitivity Without Glare 6 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Postoperative visit 3 (2-3 months) No
Primary Mesopic Monocular Contrast Sensitivity Without Glare 12 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Postoperative visit 3 (2-3 months) No
Primary Mesopic Monocular Contrast Sensitivity Without Glare 18 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Postoperative visit 3 (2-3 months) No
Primary Mesopic Monocular Contrast Sensitivity Without Glare 1.5 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Postoperative visit 4 ( 4-6 months) No
Primary Mesopic Monocular Contrast Sensitivity Without Glare 3 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Postoperative visit 4 ( 4-6 months) No
Primary Mesopic Monocular Contrast Sensitivity Without Glare 6 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Postoperative visit 4 ( 4-6 months) No
Primary Mesopic Monocular Contrast Sensitivity Without Glare 12 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Postoperative visit 4 ( 4-6 months) No
Primary Mesopic Monocular Contrast Sensitivity Without Glare 18 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Postoperative visit 4 ( 4-6 months) No
Secondary Binocular Mesopic Contrast Sensitivity Without Glare 1.5 & 3 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Binocular Mesopic Contrast Sensitivity Without Glare 6 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Binocular Mesopic Contrast Sensitivity Without Glare 12 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Binocular Mesopic Contrast Sensitivity Without Glare 18 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Binocular Mesopic Contrast Sensitivity Without Glare 1.5, 3, 6 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Binocular Mesopic Contrast Sensitivity Without Glare 12 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Binocular Mesopic Contrast Sensitivity Without Glare 18 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 1.5 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 3 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 6 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 12 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 18 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 1.5 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 3 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 6 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 12 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Mesopic Monocular Contrast Sensitivity With Glare 18 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Mesopic Binocular Contrast Sensitivity With Glare 1.5, 3 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Mesopic Binocular Contrast Sensitivity With Glare 6 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Mesopic Binocular Contrast Sensitivity With Glare 12 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Mesopic Binocular Contrast Sensitivity With Glare 18 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 3 (2-3 months) No
Secondary Mesopic Binocular Contrast Sensitivity With Glare 1.5, 3 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Mesopic Binocular Contrast Sensitivity With Glare 6 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Mesopic Binocular Contrast Sensitivity With Glare 12 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Mesopic Binocular Contrast Sensitivity With Glare 18 Cycles/Degree Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity Visit 4 (4-6 months) No
Secondary Optical Scatter Objective scatter index (OSI) was assessed using the Optical Quality Analysis System(OQAS) and summarized as a continuous variable. For this assessment, an OSI score of 1 or less represents good quality vision, 1-2 indicates some degradation but otherwise normal vision, 2-3 significant light scatter possibly requiring treatment, and scores over 4 severely compromised vision requiring intervention. Visit 3 (2-3 months) No
Secondary Optical Scatter Objective scatter index (OSI) was assessed using the Optical Quality Analysis System(OQAS) and summarized as a continuous variable. For this assessment, an OSI score of 1 or less represents good quality vision, 1-2 indicates some degradation but otherwise normal vision, 2-3 significant light scatter possibly requiring treatment, and scores over 4 severely compromised vision requiring intervention. Visit 4 (4-6 months) No
Secondary Monocular Halo and Starburst Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome. Visit 3 (2-3 months) No
Secondary Monocular Halo and Starburst Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome. Visit 4 (4-6 months) No
Secondary Binocular Halo and Starburst Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome. Visit 3 (2-3 months) No
Secondary Binocular Halo and Starburst Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome. Visit 4 (4-6 months) No
Secondary Manifest Refraction Manifest refraction spherical equivalent (MRSE) was calculated as the value of the sphere plus one-half of the value of the cylinder. Visit 3 (2-3 Months) No
Secondary Manifest Refraction Manifest refraction spherical equivalent (MRSE) was calculated as the value of the sphere plus one-half of the value of the cylinder. Visit 4 (4-6 Months) No
Secondary Uncorrected Distance Visual Acuity High Contrast Uncorrected Distance (UCDVA) measured at 32 inches, Intermediate (UCIVA) at 32 inches, and Near Visual Acuity (UCNVA) at 16 inches Visit 3 (2-3 months) Visit 4 (4-6 months) No
Secondary Best-corrected Distance Visual Acuity High Contrast Distance-Corrected Distance,(BCDVA), Intermediate (DCIVA), and Near Visual Acuity (DCNVA) Visit 3 (2-3 months) Visit 4 (4-6 months) No
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A